The most recent estimate published before the session date (JRC, December 2025) shows a 1.7% DECREASE in new cancer cases in 2024 compared with 2022, which contradicts a strictly year-on-year 'rising' reading of the claim.
The upward trend is driven mainly by population ageing and growth rather than by rising age-specific risk; in age-standardised terms cancer incidence has been relatively stable in several EU countries.
The claim conflates the number of cases (a stock/flow driven by demographics) with risk, and links it to environmental factors without providing data isolating environmental causes.